Production and purification of streptokinase by protected affinity chromatography
- PMID:23407807
- PMCID: PMC3558118
Production and purification of streptokinase by protected affinity chromatography
Abstract
Streptokinase is an extracellular protein, extracted from certain strains of beta hemolytic streptococcus. It is a non-protease plasminogen activator that activates plasminogen to plasmin, the enzyme that degrades fibrin cloth through its specific lysine binding site; it is used therefore as a drug in thrombolytic therapy. The rate of bacterial growth and streptokinase production was studied in condition of excess glucose addition to culture media and its pH maintenance. The streptokinase product of the bacterial culture was preliminary extracted by salt precipitation and then purified by affinity chromatography on plasminogen substituted sepharose-4B in a condition that the plasminogen active site was protected from streptokinase-induced activation. The purity of streptokinase was confirmed by SDS-PAGE and its biological activity determined in a specific streptokinase assay. The results showed that in the fed-batch culture, the rate of streptokinase production increased over two times as compared with the batch culture while at the same time, shortening the streptokinase purification to a single step increased the yield over 95% at the chromatography stage.
Keywords: Affinity chromatography; Culture; Plasminogen; Purification; Streptokinase.
Figures



Similar articles
- Development of an immunoaffinity method for purification of streptokinase.Karimi Z, Babashamsi M, Asgarani E, Salimi A.Karimi Z, et al.Avicenna J Med Biotechnol. 2012 Jul;4(3):142-7.Avicenna J Med Biotechnol. 2012.PMID:23408770Free PMC article.
- Purification of streptokinase by affinity chromatography on immobilized acylated human plasminogen.Rodríguez P, Hernàndez L, Muñoz E, Castro A, de la Fuente J, Herrera L.Rodríguez P, et al.Biotechniques. 1992 Mar;12(3):424-9.Biotechniques. 1992.PMID:1533307
- Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.Summaria L, Robbins KC.Summaria L, et al.J Biol Chem. 1976 Sep 25;251(18):5810-13.J Biol Chem. 1976.PMID:134997
- Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.Ferres H.Ferres H.Drugs. 1987;33 Suppl 3:33-50. doi: 10.2165/00003495-198700333-00005.Drugs. 1987.PMID:3315613Review.
- New developments in thrombolytic therapy.Collen D, Gold HK.Collen D, et al.Adv Exp Med Biol. 1990;281:333-54.Adv Exp Med Biol. 1990.PMID:2129372Review.
Cited by
- Streptokinase production from Streptococcus dysgalactiae subsp. equisimilis SK-6 in the presence of surfactants, growth factors and trace elements.Bhardwaj S, Angayarkanni J.Bhardwaj S, et al.3 Biotech. 2015 Apr;5(2):187-193. doi: 10.1007/s13205-014-0209-x. Epub 2014 Mar 20.3 Biotech. 2015.PMID:28324574Free PMC article.
- Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria.Roe JM, Seely K, Bussard CJ, Eischen Martin E, Mouw EG, Bayles KW, Hollingsworth MA, Brooks AE, Dailey KM.Roe JM, et al.Pharmaceutics. 2023 Jul 21;15(7):2004. doi: 10.3390/pharmaceutics15072004.Pharmaceutics. 2023.PMID:37514190Free PMC article.Review.
- Mechanisms that potentially contribute to the development of post-streptococcal glomerulonephritis.Munif MR, Hart RA, Rafeek RAM, Mallawaarachchi AC, Anderson L, McMillan DJ, Sriprakash KS, Ketheesan N.Munif MR, et al.Pathog Dis. 2024 Feb 7;82:ftae024. doi: 10.1093/femspd/ftae024.Pathog Dis. 2024.PMID:39341789Free PMC article.Review.
- Fermentation, fractionation and purification of streptokinase by chemical reduction method.Karimi Z, Babashamsi M, Asgarani E, Niakan M, Salimi A.Karimi Z, et al.Iran J Microbiol. 2011 Mar;3(1):42-6.Iran J Microbiol. 2011.PMID:22347582Free PMC article.
- Development of an immunoaffinity method for purification of streptokinase.Karimi Z, Babashamsi M, Asgarani E, Salimi A.Karimi Z, et al.Avicenna J Med Biotechnol. 2012 Jul;4(3):142-7.Avicenna J Med Biotechnol. 2012.PMID:23408770Free PMC article.
References
- Schick LA, Castellino F. Direct evidence for the generation of an active site in the plasminogen moiety of the streptokinase-human plasminogen activator complex. J Biochem Biophys Res Com-mun. 1974;57(1):47–54. - PubMed
- Hoffman R, Benz EJ, Jr, Shattil SJ. Hematology: Basic principles and practice. New York: Churchill Livingstone; 1991. (Eds)
- Rodriguez P, Fuentes P, Barro M, Alvarez JG, Muñoz E, Collen D, et al. Structural domains of streptokinase involved in the interaction with plasminogen. Eur J Biochem. 1995;229(1):83–90. - PubMed
- Hermentin P, Cuesta-Linker T, Weisse J, Schmidt KH, Scheld M, Thimme M. Comparative analysis of the activity and content of different streptokinase preparations. Eur H J. 2005;26(9):933–940. - PubMed
LinkOut - more resources
Full Text Sources